These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6316193)

  • 1. Structure-activity and dose-effect relationships of the antagonism of picrotoxin-induced seizures by cholecystokinin, fragments and analogues of cholecystokinin in mice.
    Kádár T; Pesti A; Penke B; Tóth G; Zarándi M; Telegdy G
    Neuropharmacology; 1983 Oct; 22(10):1223-9. PubMed ID: 6316193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration.
    Kádár T; Pesti A; Penke B; Telegdy G
    Neuropharmacology; 1984 Aug; 23(8):955-61. PubMed ID: 6090968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of electroshock-induced seizures by cholecystokinin-related peptides in mice.
    Kádár T; Borda L; Zarándi M; Penke B; Kovács K; Telegdy G
    Acta Physiol Hung; 1987; 69(1):43-50. PubMed ID: 3591354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple treatment potentiates the anticonvulsive activity of cholecystokinin octapeptides.
    Kádár T; Penke B; Pesti A; Telegdy G
    Peptides; 1985; 6(6):1009-14. PubMed ID: 3834411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant effects of careulein and cholecystokinin octapeptide, compared with those of diazepam.
    Zetler G
    Eur J Pharmacol; 1980 Jul; 65(2-3):297-300. PubMed ID: 6249626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
    Zetler G
    Neurosci Lett; 1981 Jul; 24(2):175-80. PubMed ID: 6265841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of the C-terminal octapeptide of cholecystokinin, of three of its analogues and of caerulein in the dog.
    Meyer FD; Gyr K; Kayasseh L; Jeker L; Wall M; Trzeciak A; Gillessen D
    Experientia; 1980 Apr; 36(4):434-6. PubMed ID: 7379916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on motor behaviour, hexobarbital-induced sleep and harman-induced convulsions.
    Zetler G
    Peptides; 1982; 3(4):701-4. PubMed ID: 6291014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of tail-pinch-induced food intake by cholecystokinin octapeptides and their fragments.
    Telegdy G; Kádár T; Kovács K; Penke B
    Life Sci; 1984 Jul; 35(2):163-70. PubMed ID: 6330485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam.
    Zetler G
    Neuropharmacology; 1983 Jun; 22(6):757-66. PubMed ID: 6310434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice.
    Kádár T; Borda L; Penke B; Kovács K; Telegdy G
    Neuropeptides; 1985 Jun; 6(3):259-68. PubMed ID: 4040614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
    Zetler G
    Neuropharmacology; 1982 Aug; 21(8):795-801. PubMed ID: 6289160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways.
    Yoshida H; Tsunoda Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G735-47. PubMed ID: 9316479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats.
    Fekete M; Lengyel A; Hegedüs B; Penke B; Zarándy M; Tóth G; Telegdy G
    Eur J Pharmacol; 1984 Feb; 98(1):79-91. PubMed ID: 6325212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.
    Crawley JN; St-Pierre S; Gaudreau P
    J Pharmacol Exp Ther; 1984 Aug; 230(2):438-44. PubMed ID: 6086888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholecystokinin-related peptides on self-stimulation behaviour in rats.
    Balázs M; Schwarzberg H; Penke B; Telegdy G
    Neuropeptides; 1988 Apr; 11(3):143-5. PubMed ID: 3386789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.
    Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C
    Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.